Literature DB >> 17911135

Chlamydia trachomatis seroprevalence atlas of Finland 1983-2003.

E Lyytikäinen1, M Kaasila, P Koskela, M Lehtinen, T Patama, E Pukkala, K Tasanen, H-M Surcel, J Paavonen.   

Abstract

OBJECTIVES: To study Chlamydia trachomatis seroprevalence trends and geographical distribution over time in Finland.
MATERIALS AND METHODS: First pregnancy serum samples were retrieved from the Finnish Maternity Cohort serum bank for the subcohort of 8000 women stratified by calendar years (1983-1989, 1990-1996, 1997-2003) and age at time of sample withdrawal (14-22 and 23-28 years). C trachomatis antibodies were determined using standard major outer membrane protein peptide ELISA. The spatiotemporal variation of C trachomatis seroprevalence rates was visualised by a series of maps.
RESULTS: A decreasing C trachomatis seroprevalence trend from 1983 to 2003 was seen for both women under 23 years of age (20.8% to 10.6%) and 23-28-year-old women (19.1% to 12.5%). Constant clusters were seen around the largest cities and in eastern Finland although seroprevalence rates were generally decreasing throughout the country.
CONCLUSIONS: Only a few population-based serological studies have been undertaken on C trachomatis epidemiology over time. In Finland the seroprevalence of C trachomatis is decreasing all over the country, albeit with small clusters remaining.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17911135     DOI: 10.1136/sti.2007.027409

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  11 in total

Review 1.  Protective immunity to Chlamydia trachomatis genital infection: evidence from human studies.

Authors:  Byron E Batteiger; Fujie Xu; Robert E Johnson; Michael L Rekart
Journal:  J Infect Dis       Date:  2010-06-15       Impact factor: 5.226

2.  Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis.

Authors:  Samantha E Parker; Martha M Werler; Mika Gissler; Heljä-Marja Surcel
Journal:  Birth Defects Res       Date:  2017-02-24       Impact factor: 2.344

3.  Pgp3 antibody enzyme-linked immunosorbent assay, a sensitive and specific assay for seroepidemiological analysis of Chlamydia trachomatis infection.

Authors:  Gillian S Wills; Patrick J Horner; Rosy Reynolds; Anne M Johnson; David A Muir; David W Brown; Alan Winston; Andrew J Broadbent; David Parker; Myra O McClure
Journal:  Clin Vaccine Immunol       Date:  2009-04-08

4.  Immunoglobulin-specific responses to Chlamydia elementary bodies in individuals with and at risk for genital chlamydial infection.

Authors:  William M Geisler; Sandra G Morrison; Martha L Doemland; Shehzad M Iqbal; Jin Su; Ausra Mancevski; Edward W Hook; Richard P Morrison
Journal:  J Infect Dis       Date:  2012-10-08       Impact factor: 5.226

Review 5.  Immunity and vaccines against sexually transmitted Chlamydia trachomatis infection.

Authors:  Sarah E M Howie; Patrick J Horner; Andrew W Horne; Gary Entrican
Journal:  Curr Opin Infect Dis       Date:  2011-02       Impact factor: 4.915

6.  C. trachomatis Pgp3 antibody prevalence in young women in England, 1993-2010.

Authors:  Paddy Horner; Kate Soldan; Sueli M Vieira; Gillian S Wills; Sarah C Woodhall; Richard Pebody; Anthony Nardone; Elaine Stanford; Myra O McClure
Journal:  PLoS One       Date:  2013-08-21       Impact factor: 3.240

7.  Interleukin-13 promotes susceptibility to chlamydial infection of the respiratory and genital tracts.

Authors:  Kelly L Asquith; Jay C Horvat; Gerard E Kaiko; Alison J Carey; Kenneth W Beagley; Philip M Hansbro; Paul S Foster
Journal:  PLoS Pathog       Date:  2011-05-05       Impact factor: 6.823

8.  Chlamydia trachomatis infection control programs: lessons learned and implications for vaccine development.

Authors:  Jean M Chavez; Rodolfo D Vicetti Miguel; Thomas L Cherpes
Journal:  Infect Dis Obstet Gynecol       Date:  2011-11-14

9.  A discrepancy of Chlamydia trachomatis incidence and prevalence trends in Finland 1983-2003.

Authors:  Erika Lyytikäinen; Marjo Kaasila; Eija Hiltunen-Back; Matti Lehtinen; Kaisa Tasanen; Heljä-Marja Surcel; Pentti Koskela; Jorma Paavonen
Journal:  BMC Infect Dis       Date:  2008-12-18       Impact factor: 3.090

10.  Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study.

Authors:  Patrick J Horner; Gillian S Wills; Antoinette Righarts; Sueli Vieira; Daphne Kounali; Dhanraj Samuel; Alan Winston; David Muir; Nigel P Dickson; Myra O McClure
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.